IOVA vs. CABA
IOVA (Iovance Biotherapeutics, Inc.) and CABA (Cabaletta Bio, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, IOVA returned -30.33%/yr vs -16.01%/yr for CABA. At a 0.33 correlation, their price movements are largely independent.
Performance
IOVA vs. CABA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IOVA achieves a 48.72% return, which is significantly higher than CABA's 37.44% return.
IOVA
- 1D
- 3.84%
- 1M
- -1.22%
- YTD
- 48.72%
- 6M
- 46.04%
- 1Y
- 105.05%
- 3Y*
- -20.47%
- 5Y*
- -30.33%
- 10Y*
- -6.39%
CABA
- 1D
- 5.99%
- 1M
- -17.53%
- YTD
- 37.44%
- 6M
- 25.94%
- 1Y
- 68.16%
- 3Y*
- -37.97%
- 5Y*
- -16.01%
- 10Y*
- —
IOVA vs. CABA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 48.72% | -63.11% | -8.98% | 27.23% | -66.53% | -58.86% | 67.63% | 36.49% |
CABA Cabaletta Bio, Inc. | 37.44% | -3.52% | -90.00% | 145.41% | 144.06% | -69.63% | -10.67% | 55.22% |
Correlation
The correlation between IOVA and CABA is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.36 |
Correlation (All Time) Calculated using the full available price history since Oct 25, 2019 | 0.33 |
Fundamentals
IOVA:
$1.70B
CABA:
$337.20M
IOVA:
-$0.93
CABA:
-$1.85
IOVA:
2.35
CABA:
3.26
IOVA:
$285.61M
CABA:
$0.00
IOVA:
$327.04M
CABA:
$148.00K
IOVA:
-$325.45M
CABA:
-$181.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IOVA vs. CABA — Risk / Return Rank
IOVA
CABA
IOVA vs. CABA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and Cabaletta Bio, Inc. (CABA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IOVA | CABA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.39 | ||
| Sortino ratioReturn per unit of downside risk | +0.25 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.21 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.94 | 1.58 | +0.37 |
| Martin ratioReturn relative to average drawdown | 3.05 | 3.20 | -0.15 |
Loading charts...
Drawdowns
IOVA vs. CABA - Drawdown Comparison
The maximum IOVA drawdown since its inception was -99.37%, roughly equal to the maximum CABA drawdown of -96.63%. Use the drawdown chart below to compare losses from any high point for IOVA and CABA.
Loading charts...
Drawdown Indicators
| IOVA | CABA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -96.63% | -2.74% |
Max Drawdown (1Y)Largest decline over 1 year | -54.41% | -43.49% | -10.92% |
Max Drawdown (3Y)Largest decline over 3 years | -90.50% | -95.90% | +5.40% |
Max Drawdown (5Y)Largest decline over 5 years | -93.99% | -95.90% | +1.91% |
Max Drawdown (10Y)Largest decline over 10 years | -96.84% | — | — |
Current DrawdownCurrent decline from peak | -97.45% | -88.14% | -9.31% |
Average DrawdownAverage peak-to-trough decline | -84.18% | -59.82% | -24.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.61% | 21.47% | +13.14% |
Volatility
IOVA vs. CABA - Volatility Comparison
Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 25.62% compared to Cabaletta Bio, Inc. (CABA) at 16.56%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than CABA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IOVA | CABA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.62% | 16.56% | +9.06% |
Volatility (6M)Calculated over the trailing 6-month period | 64.08% | 61.83% | +2.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 101.54% | 104.72% | -3.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 89.88% | 113.58% | -23.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.44% | 109.47% | -28.03% |
Dividends
IOVA vs. CABA - Dividend Comparison
Neither IOVA nor CABA has paid dividends to shareholders.
Financials
IOVA vs. CABA - Financials Comparison
This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and Cabaletta Bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IOVA and CABA have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IOVA has higher volatility (25.62%) compared to CABA (16.56%). In terms of maximum drawdown, IOVA dropped -99.37% vs CABA's -96.63%.
IOVA currently has the higher Sharpe Ratio (1.04 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IOVA and CABA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer